Filtering by content type: Press Release
The Federal Trade Commission and the Department of Justice are extending the Feb. 11, 2020 deadline for comments on the draft Vertical Merger Guidelines. The deadline is now Feb. 26.
Federal Trade Commission Chairman Joseph J. Simons today joined Food and Drug Administration Commissioner Stephen Hahn in signing a joint statement promoting competition in biologics markets.
The Federal Trade Commission today authorized staff of the Bureau of Competition to file suit to enjoin Edgewell Personal Care Company’s proposed $1.37 billion acquisition of its key competitor, Harry’s, Inc. The Commission’s complaint alleges that the proposed combination would eliminate one of...
The Federal Trade Commission has closed its investigation into the proposed merger of Aveanna Healthcare and Maxim Healthcare.
For 2020, the size-of-transaction threshold for reporting proposed mergers and acquisitions under Section 7A of the Clayton Act will adjust from $90 million to $94 million. Also, the 2020 thresholds under Section 8 of the Act that trigger prohibitions on certain interlocking memberships on...
Following a recent public workshop on non-compete clauses in employer-employee contracts, the Federal Trade Commission has extended the deadline for public comments from Feb. 10, 2020 to March 11, 2020.
The Federal Trade Commission has filed a complaint in federal court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim.
The Federal Trade Commission is currently accepting public comments on an application by Par Petroleum Corp. to modify the Amended Honolulu Terminal Agreement.
Filtering by content type: Public Event
The workshop will be the second in a two-part series hosted together with the Department of Justice. The two workshops will allow for a dynamic discussion about the proposed guidelines to complement the written public comments about the proposed guidelines that were submitted to the...
Filtering by content type: Public Statement
Filtering by content type: Blog Post
When Congress passed the Hart-Scott-Rodino Antitrust Improvements Act of 1976, it created minimum dollar thresholds to limit the burden of premerger reporting. In 2000, it amended the HSR statute to require the annual adjustment of these thresholds based on the change in gross...
Filtering by content type: Federal Register Notice
Filtering by content type: Case
The Federal Trade Commission has filed a complaint in federal district court against Vyera Pharmaceuticals, LLC, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim. The Commission vote to issue the complaint was 5-0. The complaint...